Ultrasound assessment of residual abnormalities following primary chemotherapy for breast cancer
1997

Ultrasound Assessment of Breast Cancer After Chemotherapy

Sample size: 52 publication Evidence: moderate

Author Information

Author(s): MT Seymour, EC Moskovic, G Walsh, P Trott, IE Smith

Primary Institution: The Royal Marsden Hospital

Hypothesis

The study aims to assess the usefulness of ultrasonography in evaluating breast abnormalities after primary chemotherapy for large operable breast cancer.

Conclusion

Ultrasound is a sensitive technique for assessing the response to primary medical therapy in breast cancer, particularly in patients who achieve complete clinical response.

Supporting Evidence

  • 60% of patients achieved complete clinical response after chemotherapy.
  • Ultrasound findings were not always indicative of residual cancer.
  • Patients with Doppler positivity were more likely to have residual invasive carcinoma.

Takeaway

Doctors used ultrasound to check how well chemotherapy worked for breast cancer, and it helped them decide if surgery was needed.

Methodology

Patients were assessed using manual palpation and color Doppler ultrasound before and after chemotherapy, with histological evaluations performed on surgical specimens.

Potential Biases

The lack of blinding in assessments could lead to biased interpretations of ultrasound results.

Limitations

The study did not formally blind clinical and ultrasound assessments, which may introduce bias.

Participant Demographics

Patients were under 65 years old, with a median age of 45, and included both premenopausal and peri/post-menopausal women.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication